Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2: Effects on Intestinal Morphology and Absorption, Renal Function, Bone and Body Composition, and Muscle Function

Background and aims. In a short-term study, Glucagon-like peptide 2 (GLP-2) has been shown to improve intestinal absorption in short bowel syndrome (SBS) patients. This study describes longitudinal changes in relation to GLP-2 treatment for two years. Methods. GLP-2, 400 micrograms, s.c.,TID, were o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeppesen, P. B., Lund, P., Gottschalck, I. B., Nielsen, H. B., Holst, J. J., Mortensen, J., Poulsen, S. S., Quistorff, B., Mortensen, P. B.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729387/
https://www.ncbi.nlm.nih.gov/pubmed/19707516
http://dx.doi.org/10.1155/2009/616054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729387/
https://www.ncbi.nlm.nih.gov/pubmed/19707516
http://dx.doi.org/10.1155/2009/616054

Ejemplares similares